It has been an honor and a privilege to be in community with all our #gyncsm participants and supporters. Here's the recap of our final chat: And you can continue to access all the resources on our blog:

RT @CancerNetwrk: Patients undergoing major gynecologic oncology surgery categorized as elderly—those older than 65 years of age—or frail e…

RT @mtmdphd: Racial differences in TMB measures b/w paired tumor/normal & tumor-only sequencing across endometrial, bladder & non-small cel…

RT @TargetedOnc: Single-agent azenosertib generated an overall response rate of 34.9% among the 43 response-evaluable, heavily pretreated p…

RT @CancerNetwrk: Anant Madabhushi, PhD, and Farzad Fereidouni, PhD, are developing the MarginCall technology to reduce time lag and improv…

RT @OncLive: Gemogenovatucel-T Receives @US_FDA RMAT Designation for Advanced HRP Ovarian Cancer #gyncsm #medtwitter #oncology https://t.c…

RT @OncLive: Frontline dostarlimab plus chemotherapy has been approved in the EU for all adult patients with primary advanced or recurrent…

RT @ocrahope: More women are facing cancer at younger ages, says a recent @AmericanCancer report. Cancer incidence rates for females under…

RT @ovarcome: RSVP via🔗: What questions are top of mind for you in #ovariancancer diagnosis, treatment, recurrence…

RT @ovarcome: February is #NationalCancerPrevention month. What better way to observe than to Connect Ovar Coffee☕️ with Dr. @KaraLongRoche…

RT @indepso: The June meeting offers just as rich a blend of academics and networking. We are curating a special program that offers some…

RT @ovarcome: Now available also on our #podcast on all platforms where you are! Thank you Dr. @SwisherLiz for the insightful, heartfelt an…

RT @womenofteal: Clinical Insights in to Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline by Dr Tew…

RT @OncLive: High-Grade Cancer, But Not SVM, Is Associated With OS Disparities in Black Patients With Uterine Carcinoma @SGO_org #SGOMtg #g…

RT @OncLive: Dr Secord on the National Academies of Sciences, Engineering, and Medicine’s Assessment of Women’s Health Research at the NIH…

RT @dsmgyo: Does #Chemoradiotherapy Boost Survival in #EndometrialCancer? The long-term results of @GOG 258 from Dr. @matei_dem on behalf…

RT @IJGConline: #Images Gastrointestinal stromal tumor mimicking a gynecologic mass @ginecooncolap 📷 @pedroramir…

RT @CACancerJournal: Thank you @OncoAlert for highlighting the @AmericanCancer Cancer Statistics 2025 report in today's #OncoAlert Video Jo…

RT @IGCSociety: 🎙️ Don’t miss this IGCS Journal Club! Explore Tisotumab Vedotin as a second- or third-line therapy for recurrent cervical c…

RT @ocrahope: Vaccination against HPV is highly effective at preventing cervical cancer. Learn more at #CervicalCa…

RT @ovarcome: Our incredible Board Member Dr. Aparna Kamat raises awareness on #OvarianCancer and shares the B.E.A.C.H.! Thank you @Newswee…